Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
TXMDCompany Name
THERAPEUTICSMD INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQTHERAPEUTICSMD INC - Price to Earnings Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TXMD - P/E Historical data
| Date | Market Capitalization | Net Income Common Stock | Price to Earnings |
|---|---|---|---|
| 6/30/2025 | $ 12.79M | $ -459K | 0 |
| 3/31/2025 | $ 17.59M | $ -2.1M | 0 |
| 12/31/2024 | $ 12.15M | $ -2.18M | 0 |
| 9/30/2024 | $ 17.3M | $ -3.32M | 0 |
| 6/30/2024 | $ 19.26M | $ -6.08M | 0 |
| 3/31/2024 | $ 23.41M | $ -7.41M | 0 |
| 12/31/2023 | $ 26.41M | $ -10.28M | 0 |
| 9/30/2023 | $ 21.26M | $ 68.31M | 0.31 |
| 6/30/2023 | $ 40.71M | $ 42.72M | 0.95 |
| 3/31/2023 | $ 45.05M | $ 157.41M | 0.29 |
Key Performance Insights, Last 5 Years
- THERAPEUTICSMD INC's latest trailing twelve months (TTM) P/E stands at 0.
- Over the past 5 years, THERAPEUTICSMD INC's average P/E has been 0.47.
- The median P/E for THERAPEUTICSMD INC during this period was 0.31
- THERAPEUTICSMD INC reached its highest P/E over the past 5 years at 0.95.
- The lowest P/E recorded by THERAPEUTICSMD INC in the same timeframe 0.29
THERAPEUTICSMD INC's P/E vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/E Benchmarks
Similar metrics to P/E:
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Price to Earnings
[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.Market Cap / Net Inc. Cmn.
(=) P/E P/E for THERAPEUTICSMD INC is calculated as follows: Market Cap [ $ 414.67M ] / Net Inc. Cmn. [ $ -190.87M ]
(=) P/E [ 0 ] TXMD - Price to Earnings, Last 5 years
0.29
Minimum
Mar 31, 2023
0.95
Maximum
Jun 30, 2023
0.47
Average
0.31
Median
P/E Benchmark AnalysisMarket
The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.52 with a standard deviation of 13.95.
The following table provides additional summary stats:
P/E in the Market:
| filtered constituents | 2.07K |
|---|---|
| min | 0.13 |
| max | 70.11 |
| average | 22.52 |
| median | 18.89 |
| std | 13.95 |